Advancements in prophylactic and therapeutic nanovaccines

Vaccines activate suitable immune responses to fight against diseases but can possess limitations such as compromised efficacy and immunogenic responses, poor stability, and requirement of adherence to multiple doses. ‘Nanovaccines’ have been explored to elicit a strong immune response with the adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhardwaj, Prateek, Bhatia, Eshant, Sharma, Shivam, Ahamad, Nadim, Banerjee, Rinti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Acta Materialia Inc. Published by Elsevier Ltd. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163188/
https://www.ncbi.nlm.nih.gov/pubmed/32268235
http://dx.doi.org/10.1016/j.actbio.2020.03.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163188/
https://www.ncbi.nlm.nih.gov/pubmed/32268235
http://dx.doi.org/10.1016/j.actbio.2020.03.020

Ejemplares similares